Adipocyte reporter assays: Application for identification of anti-inflammatory and antioxidant properties of mangosteen xanthones

Molecular Nutrition and Food Research

Volumn 58, Issue 2, 2014, Pages 239-247

  Shen, Qiwen ^a   Chitchumroonchokchai, Chureeporn ^a   Thomas, Jaisa L ^a   Gushchina, Liubov V ^a   Disilvestro, David ^a   Failla, Mark L ^a   Ziouzenkova, Ouliana ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Mangosteen; Nrf2; Nuclear receptors; Obesity

Indexed keywords

ADIPONECTIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFE2L2 PROTEIN, MOUSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR NRF2; XANTHONE DERIVATIVE;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CHEMISTRY; DRUG EFFECT; FRUIT; GARCINIA MANGOSTANA; GENETIC PROCEDURES; GENETICS; INFLAMMATION; LENTIVIRINAE; MANGOSTEEN; METABOLISM; MOUSE; NRF2; NUCLEAR RECEPTORS; OBESITY; PROMOTER REGION;

INFLAMMATION; MANGOSTEEN; NRF2; NUCLEAR RECEPTORS; OBESITY;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOSENSING TECHNIQUES; CELL DIFFERENTIATION; FATTY ACID-BINDING PROTEINS; FRUIT; GARCINIA MANGOSTANA; LENTIVIRUS; MICE; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PPAR GAMMA; PROMOTER REGIONS, GENETIC; XANTHONES;

EID: 84893386026     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300181     Document Type: Article

References (38)

1. Berghofer, A., Pischon, T., Reinhold, T., Apovian, C. M. et al., Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008, 8, 200.
2. Ogden, C. L., Carroll, M. D., Kit, B. K., Flegal, K. M., Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012, 1-8.
3. Baker, R. G., Hayden, M. S., Ghosh, S., NF-kappa B, inflammation, and metabolic disease. Cell Metab. 2011, 13, 11-22.
4. Kershaw, E. E., Flier, J. S., Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 2004, 89, 2548-2556.
5. Calle, E. E., Kaaks, R., Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4, 579-591.
6. Berg, A. H., Scherer, P. E., Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96, 939-949.
7. Wisse, B. E., The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J. Am. Soc. Nephrol. 2004, 15, 2792-2800.
8. Sartipy, P., Loskutoff, D. J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003, 100, 7265-7270.
9. Dahlman, I., Kaaman, M., Olsson, T., Tan, G. D. et al., A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J. Clin. Endocrinol. Metab. 2005, 90, 5834-5840.
10. Kanda, H., Tateya, S., Tamori, Y., Kotani, K. et al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116, 1494-1505.
11. Zhao, J., Nutraceuticals, nutritional therapy, phytonutrients, and phytotherapy for improvement of human health: a perspective on plant biotechnology application. Recent Pat. Biotechnol. 2007, 1, 75-97.
12. Obolskiy, D., Pischel, I., Siriwatanametanon, N., Heinrich, M., Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother. Res. 2009, 23, 1047-1065.
13. Mahabusarakam, W., Wiriyachitra, P., Taylor, W. C., Chemical constituents of Garcinia mangostana. J. Nat. Prod. 1987, 50, 474-478.
14. Quan, X., Wang, Y., Ma, X., Liang, Y. et al., Alpha-mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase. PLoS One 2012, 7, e33376.
15. Bumrungpert, A., Kalpravidh, R. W., Chitchumroonchokchai, C., Chuang, C. C. et al., Xanthones from mangosteen prevent lipopolysaccharide-mediated inflammation and insulin resistance in primary cultures of human adipocytes. J. Nutr. 2009, 139, 1185-1191.
16. Pamukcu, B., Lip, G. Y., Shantsila, E., The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb. Res. 2011, 128, 117-123.
17. Berg, A. H., Lin, Y., Lisanti, M. P., Scherer, P. E., Adipocyte differentiation induces dynamic changes in NF-kappaB expression and activity. Am. J. Physiol. Endocrinol. Metab. 2004, 287, E1178-E1188.
18. Rosen, E. D., Spiegelman, B. M., PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 2001, 276, 37731-37734.
19. Lefterova, M. I., Zhang, Y., Steger, D. J., Schupp, M. et al., PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev. 2008, 22, 2941-2952.
20. Chen, F., Wang, M., O'Connor, J. P., He, M., Tripathi, T. et al., Phosphorylation of PPARgamma via active ERK1/2 leads to its physical association with p65 and inhibition of NF-kappa beta. J. Cell. Biochem. 2003, 90, 732-744.
21. Tang, T., Zhang, J., Yin, J., Staszkiewicz, J. et al., Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J. Biol. Chem. 2010, 285, 4637-4644.
22. Pi, J., Leung, L., Xue, P., Wang, W. et al., Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J. Biol. Chem. 2010, 285, 9292-9300.
23. Li, W., Khor, T. O., Xu, C., Shen, G. et al., Activation of Nrf2-antioxidant signaling attenuates NF-kappa B-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76, 1485-1489.
24. Tontonoz, P., Spiegelman, B. M., Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 2008, 77, 289-312.
25. Chaivisuthangkura, A., Malaikaew, Y., Chaovanalikit, A., Jaratrungtawee, A. et al., Prenylated xanthone composition of Garcinia mangostana (mangosteen) fruit hull. Chromatographia 2009, 69, 315-318.
26. Green, H., Meuth, M., An established pre-adipose cell line and its differentiation in culture. Cell 1974, 3, 127-133.
27. Yasmeen, R., Reichert, B., Deiuliis, J., Yang, F. et al., Autocrine function of aldehyde dehydrogenase 1 as a determinant of diet- and sex-specific differences in visceral adiposity. Diabetes 2013, 62, 124-136.
28. Celec, P., Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed. Pharmacother. 2004, 58, 365-371.
29. Camp, H. S., Li, O., Wise, S. C., Hong, Y. H. et al., Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 2000, 49, 539-547.
30. Mao, J. W., Tang, H. Y., Wang, Y. D., Influence of rosiglitazone on the expression of PPARgamma, NF-kappaB, and TNF-alpha in rat model of ulcerative colitis. Gastroenterol. Res. Pract. 2012, 2012, 845672.
31. Ferrante, A. W., Jr., Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 2007, 262, 408-414.
32. Hajer, G. R., van der Graaf, Y., Olijhoek, J. K., Edlinger, M. et al., Low plasma levels of adiponectin are associated with low risk for future cardiovascular events in patients with clinical evident vascular disease. Am. Heart J. 2007, 154, 750.e1-750.e7.
33. Wang, X. J., Hayes, J. D., Henderson, C. J., Wolf, C. R., Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha. Proc. Natl. Acad. Sci. USA 2007, 104, 19589-19594.
34. Yasmeen, R., Jeyakumar, S. M., Reichert, B., Yang, F. et al., The contribution of vitamin A to autocrine regulation of fat depots. Biochim. Biophys. Acta 2012, 1821, 190-197.
35. Liu, M. J., Bao, S., Bolin, E. R., Burris, D. L. et al., Zinc deficiency augments leptin production and exacerbates macrophage infiltration into adipose tissue in mice fed a high-fat diet. J. Nutr. 2013, 143, 1036-1045.
36. Medina-Gomez, G., Gray, S., Vidal-Puig, A., Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr. 2007, 10, 1132-1137.
37. Singh, S., Vrishni, S., Singh, B. K., Rahman, I. et al., Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic. Res. 2010, 44, 1267-1288.
38. Schneider, K. S., Chan, J. Y., Emerging role of nrf2 in adipocytes and adipose biology. Adv. Nutr. 2013, 4, 62-66.